CSIMarket


Centogene N v   (CNTG)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


 

Centogene N v

CNTG's Financial Statements and Analysis



Centogene N v increased forth quarter of 2023 net loss per share of $-1.42 compare to net loss per share of $-1.33 recorded in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.


forth quarter of 2023
Earnings Per Share Revenues
$ -1.42 $  54 Mill
$-0.09     $+1M     +2.16 %



Centogene N V 's Revenue rose by 2.16 % in forth quarter of 2023 (Dec 31 2023) year on year, to $54 million and advanced by sequentially.


Centogene N V is

More on CNTG's Income Statement



Centogene N V in the forth quarter of 2023 recorded net loss of $-39.796 million, an increase from net loss of $-35.662 million in IV. Quarter a year ago.

Sequentially company realized a net loss, compared to net income of $0.000 million in the previous quarter.

More on CNTG's Growth

Centogene N V Inventories
CNTG's Cash flow In the forth quarter of 2023 company's net cash flow was $40 million, capital expenditures grew by -0.41104-89.10%, to $0 millions compare to same quarter a year ago

More on CNTG's Cash flow Statement


Centogene N v does not pay out common stock dividend.

In trailing twelve-month period Centogene N v payed $ -1.27 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -1.01 per share from $ -1.01.

Company repurchased 0.00 million shares or 0.00 % in Dec 31 2023.


More on CNTG's Dividends

 Market Capitalization (Millions) 11
 Shares Outstanding (Millions) 28
 Total Debt (Millions $) 45
 Revenue (TTM) (Millions $) 54
 Net Income (TTM) (Millions $) -40
 Cash Flow (TTM) (Millions $) 40
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 500




Centogene N v does not pay out common stock dividend.

In trailing twelve-month period Centogene N v had negative $ -1.27 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -1.01 per share from $ -1.01.

Company repurchased 0.00 million shares or 0.00 % in Dec 31 2023.


More on CNTG's Balance Sheets

 Market Capitalization (Millions) 11
 Shares Outstanding (Millions) 28
 Total Debt (Millions $) 45
 Revenue (TTM) (Millions $) 54
 Net Income (TTM) (Millions $) -40
 Cash Flow (TTM) (Millions $) 40
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 500
   


  News about Centogene N v Earnings